Lumosa Therapeutics Co., Ltd. (TPEX:6535)
158.00
-10.00 (-5.95%)
Mar 4, 2026, 1:30 PM CST
-30.09% (1Y)
| Market Cap | 28.30B |
| Revenue (ttm) | 35.83M |
| Net Income (ttm) | -340.54M |
| Shares Out | 168.46M |
| EPS (ttm) | -2.05 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 316,002 |
| Average Volume | 283,179 |
| Open | 164.00 |
| Previous Close | 168.00 |
| Day's Range | 158.00 - 164.00 |
| 52-Week Range | 122.00 - 329.50 |
| Beta | 0.04 |
| RSI | 32.83 |
| Earnings Date | Mar 11, 2026 |